Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive income (loss)	Accumulated Deficit
Beginning balance at Dec. 31, 2020	$ 7,451	$ 0	$ 1	$ 0	$ 50,096	$ (3)	$ (42,643)
Beginning balance (in shares) at Dec. 31, 2020		0	66,155,340	9,896,666
Shares issued during the period for vested restricted stock awards, Shares			9,107,121
Acquisition of treasury stock			(865,900)	865,900
Issuance of common stock upon exercise of stock options	317		$ 1		316
Issuance of common stock upon exercise of stock options (in shares)			2,838,464
Sale of shares	241,155		$ 2		241,153
Sale of shares, shares			19,840,000
Stock offering costs	(7,088)				(7,088)
Repurchase and retirement of common stock held by related parties	(54,155)		$ (1)		(54,154)
Shares acquired and retired			(4,455,384)
Impact of Stock Split			$ 6		(6)
Stock-based compensation	61,765				61,765
Net Income (Loss)	(106,589)						(106,589)
Other comprehensive loss	10					10
Ending balance at Dec. 31, 2021	142,866	$ 0	$ 9	$ 0	292,082	7	(149,232)
Ending balance (in shares) at Dec. 31, 2021		0	92,619,641	10,762,566
Shares issued during the period for vested restricted stock awards, Value	4,062		$ 1		4,061
Shares issued during the period for vested restricted stock awards, Shares			8,096,868
Issuance of common stock upon exercise of stock options	903		$ 1		902
Issuance of common stock upon exercise of stock options (in shares)			3,316,079
Shares issued for HX Tracker acquisition, Amount	4,370				4,370
Shares issued for HX Tracker acquisition, Shares			1,000,000
Stock-based compensation	13,930				13,930
Net Income (Loss)	(99,613)						(99,613)
Other comprehensive loss	(68)					(68)
Ending balance at Dec. 31, 2022	66,450	$ 0	$ 11	$ 0	315,345	(61)	(248,845)
Ending balance (in shares) at Dec. 31, 2022		0	105,032,588	10,762,566
Shares issued during the period for vested restricted stock awards, Value	4,861		$ 1		4,860
Shares issued during the period for vested restricted stock awards, Shares			3,787,996
Issuance of common stock upon exercise of stock options	$ 226				226
Issuance of common stock upon exercise of stock options (in shares)	717,960		717,960
Shares issued for legal settlement	$ 2,000				2,000
Shares issued for legal settlement, shares			797,396
Sale of shares	34,007		$ 1		34,006
Sale of shares, shares			15,421,885
Stock offering costs	(297)				(297)
Shares acquired and retired			(312,500)
Stock-based compensation	5,746				5,746
Net Income (Loss)	(50,290)						(50,290)
Other comprehensive loss	(232)					(232)
Ending balance at Dec. 31, 2023	$ 62,471	$ 0	$ 13	$ 0	$ 361,886	$ (293)	$ (299,135)
Ending balance (in shares) at Dec. 31, 2023		0	125,445,325	10,762,566